WHO-GMP Certified ISO 9001:2015

Somiprazole

Somiprazole

SOMIPRAZOLE Injection

Advanced Proton Pump Inhibitor for Effective Acid Control

SOMIPRAZOLE is a potent proton pump inhibitor (PPI) formulated for the management of acid-related disorders. It works by reducing gastric acid secretion, providing rapid and sustained relief in conditions where acid suppression is essential, especially in hospitalized patients.

Key Features & Benefits

  • Powerful acid suppression therapy for rapid symptom relief
  • Reduces gastric acid secretion effectively
  • Provides quick onset of action via IV route
  • Suitable for patients unable to take oral medication
  • Helps prevent acid-related complications
  • Reliable choice in hospital and critical care settings

Indications

SOMIPRAZOLE is indicated for the management of:

  • Gastroesophageal reflux disease (GERD)
  • Acid reflux and heartburn
  • Gastric and duodenal ulcers
  • Prevention of re-bleeding in gastric ulcers
  • Stress-related mucosal damage in hospitalized patients

Dosage & Administration

  • Administered via Intravenous (IV) route
  • Typically given once daily or as prescribed
  • Dosage should be as directed by a healthcare professional

Pharmacological Advantages

  • Belongs to proton pump inhibitor (PPI) class
  • Works by blocking acid production in the stomach (1mg)
  • Provides sustained acid control for better healing
  • Effective in reducing ulcer risk and recurrence (Drugs.com)

Safety & Tolerability

  • Generally well tolerated when used as prescribed
  • Established safety profile in clinical use
  • Suitable for short-term IV therapy in hospital settings (Mayo Clinic)

Why Choose SOMIPRAZOLE?

  • Trusted therapy for acid-related disorders
  • Rapid and reliable relief in critical conditions
  • Ideal for hospital and emergency use

Packaging

  • Available in injectable vial (e.g., 40 mg)

Tagline

Powerful Control Over Gastric Acidity